Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL-Reference-Cited by-同舟云学术

Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL

Published:2013-02-27 Issue:4 Volume:30 Page:355-364
ISSN:0934-0866
Container-title:Particle & Particle Systems Characterization
language:en
Short-container-title:Particle Particle Systems Characterization

Author:

Raghunathan Rekha¹,Mahesula Swetha¹,Kancharla Kranthi¹,Janardhanan Preethi²,Jadhav Yeshwant L. A.¹,Nadeau Robert,Villa German P.³,Cook Robert L.³,Witt Colleen M.³,Gelfond Jonathan A. L.⁴,Forsthuber Thomas G.²,Haskins William E.¹

Affiliation:

1. Pediatric Biochemistry Laboratory; Department of Chemistry-BSE 3.108A; University of Texas at San Antonio; One UTSA Circle; San Antonio; TX; 78249; USA

2. Department of Biology; University of Texas at San Antonio; One UTSA Circle; San Antonio; TX; 78249; USA

3. Department of Physics; University of Texas at San Antonio; One UTSA Circle; San Antonio; TX; 78249; USA

4. Department of Epidemiology & Biostatistics; University of Texas Health Science Center at San Antonio; San Antonio; TX; 78229; USA

Publisher

Wiley

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Reference57 articles.

1. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia

2. Cancer incidence among Hispanic children in the United States

3. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations

4. Class prediction models of thrombocytosis using genetic biomarkers

5. Racial Differences in the Survival of Childhood B-Precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia;International Journal of Biological Macromolecules;2024-01

2. Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies;Nanoscale Advances;2023

3. A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia;International Journal of Biological Macromolecules;2021-11

4. Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in CRLF2-Rearranged Ph-like ALL;Molecular Cancer Research;2020-08-14

5. Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia;Oncology Reports;2018-12-07